Dr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience, as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
Even though Google Inc. has given up on the business of electronic personal health records, Fort Wayne-based NoMoreClipboard.com is launching a new service it thinks will crack open the market.
At three community health centers, all patients will be asked about their alcohol and drug usage confidentially, as part of an early-intervention approach designed to cut down addictions and reduce hospitalization.
Zotec Partners, a fast-growing physician-billing management company based in Carmel, has acquired a family-owned medical-billing firm with 100 employees based in Florida.
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
Dr. Murray Korc, an internationally known pancreatic cancer researcher, comes to the cancer center as the first Myles Brand Professor of Cancer Research. The position is funded through a Lilly Endowment grant.
Benefit consultant Nyhart says the typical Hoosier is paying $105 per month for single coverage and $417 per month for family coverage.
The top event for regulatory professionals in the health care industry is headed to Indianapolis next month. The annual conference of the Regulatory Affairs Professionals Society, or RAPS, is expected to draw thousands of members representing 120 companies and organizations.
Drugmaker Eli Lilly and Co. said Tuesday it will spend $30 million over five years to fight chronic illnesses like heart disease, diabetes, cancer and respiratory disease in developing countries.
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.
IBM’s supercomputer system, best known for trouncing the world’s best “Jeopardy!” players on TV, is being tapped by one of the nation’s largest health insurers to help diagnose medical problems and authorize treatments.
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
The Thomson Reuters study that showed Anderson as the highest-spending health care market in the nation also concluded that treatment and spending vary widely from one locale to another with no clear reason based on demographics or health outcomes.
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Indianapolis-based SynCare has ended its contract to screen Missouri Medicaid recipients after numerous complaints about its job performance.
Officials with the Missouri Department of Health and Senior Services say they had to hire 13 temporary workers and shift as many as 20 state workers from their regular jobs after withering consumer complaints against SynCare LLC of Indiana.
Indianapolis-based SynCare LLC, hired to determine the eligibility of Missouri Medicaid patients for in-home care, has "been a complete disaster from the beginning," statewide health care advocates charge.
Why not look at the entire neighborhood instead of just this old site?
Angela Smith, an attorney for hospitals and physicians at Indianapolis-based Hall Render Killian Heath & Lyman P.C., spoke about Medicare’s value-based purchasing program, a federal initiative that will attempt to shift health care payments from the fee-for-service model to one based on health outcomes. On July 1, hospitals began being scored on their performance in 13 categories, including processes, patient outcomes and patient satisfaction surveys. How hospitals score could boost or diminish all their Medicare payments by as much as 1 percent, beginning in October 2012.
New drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing systems.
